Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

AVANIR Pharmaceuticals (FazaClo Business Operations)

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer of pharmaceuticals. The unit manufactures anti-psychotic drug which are given to severely ill schizophrenic patients who fail to respond adequately to standard drug treatments for schizophrenia.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Primary Office
  • 101 Enterprise
  • Suite 300
  • Aliso Viejo, CA 92656
  • United States

AVANIR Pharmaceuticals (FazaClo Business Operations) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore AVANIR Pharmaceuticals (FazaClo Business Operations)‘s full profile, request access.

Request full access to PitchBook

AVANIR Pharmaceuticals (FazaClo Business Operations) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore AVANIR Pharmaceuticals (FazaClo Business Operations)‘s full profile, request access.

Request full access to PitchBook